E
East Coast Institute for Research | Canton, GA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RTA 901
Cadisegliatin
BW-00112
BIIB143
Parent organization
This site is a part of East Coast Institute for Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
A Phase 2 in Patients With Mixed Dyslipidemia
Active, not recruiting
Mixed Dyslipidemia
Drug: BW-00112
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.
Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo
The goal of this study is to see if directing insulin to the liver will improve the low blood sugar that sometimes happens when injecting insulin in...
Enrolling
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro
Trial sponsors
D
I
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems